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1.1 Prion diseases 
 
1.1.1 Human prion diseases 
Prion diseases occur as sporadic, genetic, and transmissible disease in humans 
(Table 1). Although infectious forms of prion disease are most well known to 
the general public, sporadic and heritable forms of the disease occur much 
more frequently in humans, with sporadic (s) Creutzfeldt-Jakob Disease (CJD) 
accounting for approximately 85% of cases. sCJD has no known cause 
although spontaneous misfolding of the cellular isoform of the prion protein 
(PrP
C) into an aberrantly folded, β-sheet-rich isoform (PrPSc) is a leading 
hypothesis (Prusiner 1989; Hsiao et al. 1991) (Fig. 1). The brains of sCJD 
patients harbour infectious prions that are transmissible to experimental 
animals (Gibbs et al. 1968; Brown et al. 1994). In humans, virtually all forms 
of prion disease feature 
neuropathological changes including vacuolation (resulting in the spongiform 
appearance of brain tissue), astrocytic gliosis, and PrP deposition. The 
morphology of vacuoles and PrP deposits varies depending on the prion strain 
and host, as do the regions of the brain affected. 
Table 1. Prion diseases of humans and animals. 
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Fig. 1. Prion structures 
 
 
To date, over 40 different mutations of the PrP gene (PRNP) have been shown 
to segregate with the heritable human prion diseases. The resulting diseases 
have been classified as Gerstmann–Sträussler–Scheinker syndrome (GSS), 
familial (f) CJD, or fatal familial insomnia (FFI) according to the clinical 
symptoms, although all result from PRNP mutations. At the time when the 
discoveries were reported that fCJD and GSS could be transmitted to apes and 
monkeys, many still thought that scrapie, CJD, and related disorders were 
caused by slow viruses (Roos et al. 1973; Masters et al. 1981). Only the 
discovery that a proline-to-leucine mutation at codon 102 of the human PRNP 
gene was genetically linked to some GSS pedigrees permitted the 
unprecedented conclusion that prion disease can have both genetic and 
infectious etiologies (Hsiao et al. 1989; Prusiner 1989). This mutation has been 
found in unrelated families from several countries, and other mutations causing 
GSS have since been identified (Dlouhy et al. 1992; Petersen et al. 1992; 
Poulter et al. 1992; Rosenmann et al. 1998). Likewise, several different 
PrP
Sc
 PrP
C
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mutations have also been discovered to cause fCJD. A repeat expansion in the 
amino-terminal region of PrP, which in the healthy population contains five 
repetitive sequences of eight residues each (octarepeats), has been genetically 
linked to fCJD. Insertions of two to nine additional octarepeats have been 
found in individuals within fCJD pedigrees (Owen et al. 1989; Goldfarb et al. 
1991a). Molecular genetic investigations have revealed that Libyan and 
Tunisian Jews with fCJD have a PRNP gene point mutation at codon 200, 
resulting in a glutamic acid-tolysine substitution (Goldfarb et al. 1990a; Hsiao 
et al. 1991b), a mutation that has since been identified in fCJD pedigrees in 
many locations (Goldfarb et al. 1990a; Goldfarb et al. 1990b; Bertoni et al. 
1992). 
The D178N mutation can cause either fCJD or FFI, depending on the 
polymorphism present at codon 129, where both methionine and valine are 
commonly found. D178N coupled with V129 produces fCJD, in which patients 
present with dementia and widespread deposition of PrP
Sc
 (Goldfarb et al. 
1991c). If the disease mutation is coupled with M129, however, FFI results 
and patients present with a progressive sleep disorder that is ultimately fatal. 
Post mortem analysis of FFI brains revealed deposition of PrP
Sc
 confined 
largely to specific regions of the thalamus (Lugaresi et al. 1986; Gambetti et al. 
1995). 
Infectious forms of prion diseases include kuru, iatrogenic (i) CJD, and variant 
(v) CJD. Kuru in the highlands of New Guineawas transmitted by ritualistic 
cannibalism, as people in the region ate the brains of their dead relatives in an 
attempt to immortalize them (Glasse 1967; Alpers 1968; Gajdusek 1977). 
Iatrogenic transmissions include prion-tainted human growth hormone and 
gonadotropin, duramater grafts, and transplants of corneas obtained from 
people who died of CJD (Koch et al. 1985; PHS 1997). In addition, CJD cases 
have been recorded after neurosurgical procedures in which ineffectively 
sterilized depth electrodes or instruments were used. More than 200 teenagers 
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and young adults have died of vCJD, mostly in Britain (Spencer et al. 2002; 
Will 2003) while two confirmed cases have been reported in Italy so far. Both 
epidemiologic and experimental studies have built a convincing case that vCJD 
resulted from prions being transmitted from cattle with bovine spongiform 
encephalopathy (BSE, or “mad cow” disease) to humans through consumption 
of contaminated beef products (Chazot et al. 1996; Will et al. 1996; Cousens et 
al. 1997). Until recently, all of the vCJD-affected individuals were identified to 
express methionine homozygously at codon 129. A single case of vCJD in a 
patient heterozygous at codon 129 has been reported, raising the possibility of 
a second wave of “mad cow”–related deaths (Kaski et al. 2009). 
 
 
1.1.2 Animal prion diseases 
Prion diseases occur naturally in many mammals, including scrapie of sheep 
and goats, BSE, transmissible mink encephalopathy (TME), chronic wasting 
disease (CWD) of mule deer and elk, feline spongiform encephalopathy, and 
exotic ungulate encephalopathy (Table 1). Unlike in humans, prion diseases in 
animals 
mainly occur as infectious disorders. As in humans, prion disease in animals is 
characterized by neuropathologic changes, including vacuolation, astrocytic 
gliosis, and PrP deposition. 
Scrapie of sheep has been documented in Europe for hundreds of years. 
Despite efforts attempting to link scrapie to CJD, no evidence exists to 
establish a relationship (Chatelain et al. 1981). Polymorphisms in sheep PrP 
modulate susceptibility to scrapie, rendering some breeds more resistant to 
infection than others (Goldmann et al. 1991). As scrapie prions can persist in 
soil for years (Palsson 1979; Brown and Gajdusek 1991), selective breeding 
programs may be the most effective means to eradicate scrapie. In part because 
scrapie is not infectious for humans, hamster- and mouse-adapted scrapie 
  
8 
strains, such as Sc237 and RML, are important laboratory tools for studying 
prions. 
During the BSE epidemic in Britain, it was estimated that nearly one million 
cattle were infected with prions (Anderson et al. 1996; Nathanson et al. 1997). 
The mean incubation time for BSE is approximately 5 years. Most cattle were 
slaughtered between 2 and 3 years of age, and therefore, in a presymptomatic 
phase of infection (Stekel et al. 1996). BSE is a massive common-source 
epidemic caused by meat and bone meal (MBM) fed primarily to dairy cows 
(Wilesmith et al. 1991; Nathanson et al. 1997). MBM was prepared from the 
offal of sheep, cattle, pigs, and chickens as a high-protein nutritional 
supplement. In the late 1970s, the hydrocarbon-solvent extraction method used 
in the rendering of offal began to be abandoned, resulting in MBM with a 
much higher fat content (Wilesmith et al. 1991; Muller et al. 2007). It is now 
thought that this change allowed scrapie prions from sheep or low levels of 
bovine prions generated sporadically to survive the rendering process, resulting 
in the widespread infection of cattle. Changes in the methods used for feeding 
cattle have since eliminated the epidemic, although sporadic BSE cases arise 
occasionally. 
Mule deer, white-tailed deer, and elk have been reported to develop CWD. As 
the only prion disease identified in free-ranging animals, CWD appears to be 
far more communicable than other forms of prion disease. CWD was first 
described in 1967 and was reported to be a spongiform encephalopathy in 1978 
on the basis of histopathology of the brain. Originally detected in the American 
West, CWD has spread across much of North America and has been reported 
also in South Korea. In captive populations, up to 90% of mule deer have been 
reported to be positive for prions (Williams and Young 1980). The incidence 
of CWD in cervids living in the wild has been estimated to be as high as 15% 
(Miller et al. 2000). The development of transgenic (Tg) mice expressing 
cervid PrP, and thus susceptible to CWD, has enhanced detection of CWD and 
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the estimation of prion titers (Browning et al. 2004; Tamugey et al. 2006). 
Shedding of prions in the feces, even in presymptomatic deer, has been 
identified as a likely source of infection for these grazing animals (Williams 
and Miller 2002; Tamguney et al. 2009b). CWD has been transmitted to cattle 
after intracerebral inoculation, although the infection rate was low (4 of 13 
animals [Hamir et al. 2001]). This finding raised concerns that CWD prions 
might be transmitted to cattle grazing in contaminated pastures. 
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1.2 The prion protein gene (PRNP) in ruminants 
The PRNP gene in sheep, goats and cattle has been mapped to chromosome 
13. The genomic sequence available around the PRNP gene locus is 32 kb in 
sheep (accession No. U67922), 27 kb in goat (accession No. EU870890), 78 kb 
in cattle (accession No. AJ298878) and 65 kb in mule deer (accession No. 
AY330343). Only the genomes of species in the genus Odocoileus (e.g. mule 
deer, white-tailed deer) contain a pseudogene (PrPψ, accession No. 
AY371694) with all the features of a classical retro-element (Brayton et al. 
2004). The functional length of the PRNP gene is approximately 21 kb and it is 
composed of three exons. Exons I and II are small (100 bp) and form the non-
coding 5‟UTR of the transcript. Exon III (~ 4 kb) contains the full open 
reading frame and the 3‟UTR of the transcript. Introns I and II are 
approximately 2.5 kb and 14 kb in length, respectively. 
All four genomes produce a messenger RNA of about 4.6 kb, but sheep and 
goat also generate in peripheral tissues by alternative polyadenylation a second 
mRNA of ~ 2.1 kb (Goldmann et al., 1999; Horiuchi et al., 1998). This short 
mRNA is produced at significant level and may be differently regulated 
compared to the long mRNA. No 2.1 kb mRNA has been detected in cattle. 
Whether the deer transcript shows alternative polyadenylation is not known. 
The specific functions of exons I and II in the 5‟UTR are also unknown. 
Differential splicing of exon II has not yet been observed, however cattle have 
a particular alternative splicing at exon I which creates either a 5‟UTR with an 
additional 115 bases (exon Ib) (Horiuchi et al., 1997) or a 5‟UTR without exon 
I (Haigh et al., 2007). Again, their role is unidentified but one could speculate 
that the different mRNA are recognised in different regulatory pathways and in 
that way protein expression could be regulated at various cellular levels. 
The gene promoter region regulates production of messenger RNA and 
consequently controls to a large extent protein expression. The amount of PrP 
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protein, PrP tissue distribution and temporal availability are therefore all 
genetically controlled. The PRNP gene promoter is active in most tissues and 
PrP mRNA can be readily detected throughout development in most ruminants 
(Goldmann et al., 1999). The ruminant PRNP promoter contains several well 
characterised transcription factor motifs within its core (e.g. SP-1, AP-2). 
Upstream of the core sequence are four motifs highly conserved in sequence 
and position between species (Westaway et al., 1994) and present in all known 
PRNP promoters; they are probably involved in the regulation of transcription. 
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1.3 The genetics of scrapie in goats 
 
1.3.1 Role of the PRNP coding region 
Natural scrapie in goats was reported for the first time in France (Chelle, 
1942), afterwards other cases were described worldwide: a state of the art 
review on goat scrapie in the European Union, including epidemiology, has 
been published by Vaccari et al. (2009). Goats are susceptible not only to 
classical scrapie, but also atypical/Nor98 scrapie cases have been detected, 
characterized, as in sheep, by distinctive features regarding epidemiology (i.e. 
occurrence as single cases in the affected herds), molecular pattern, and 
distribution of histopathological lesions. Moreover the only two confirmed 
cases of natural BSE in small ruminants were reported in goats, in France 
(Eloit et al., 2005) and in a retrospective study in UK (Jeffrey et al., 2006).  
In Italy the first case of scrapie in goat was diagnosed in 1997 (Capucchio et 
al., 1998) and, since then, 65 outbreaks have been detected in total (51 of 
classical scrapie and 14 of Nor98 scrapie), in which, according to the foreseen 
measures for the eradication of the disease, 13.000 goats have been culled. 
Although scrapie is an infectious disease, the susceptibility of sheep is strongly 
influenced by polymorphisms of the prion protein gene (PRNP). PRNP 
haplotypes valine/arginine/glutamine (VRQ) and alanine/arginine/glutamine 
(ARQ) at codons 136, 154, 171, respectively, are associated with high 
susceptibility to classical scrapie, whereas the ARR haplotype has been linked 
to resistance (Belt et al., 1995; Bossers et al., 1996; Hunter et al., 1996; Hunter 
et al., 1997) (Fig. 2). Accordingly, the EU has implemented breeding programs 
to increase scrapie resistance in sheep populations. In compliance with 
regulation (EC) 999/2001, as amended, several Member States are now 
increasing the frequency of the ARR haplotype. A similar approach is not 
applied in goats yet but it would be desirable in this species too, given that 
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scrapie poses a problem for the economy and for animal welfare, and that 
goats, often bred in mixed flocks with sheep, can have a role in maintaining the 
circulation of scrapie strain and the consequent sheep exposure. Genetic 
analysis of the goat PRNP gene revealed 42 polymorphisms in the open 
reading frame (Vaccari et al., 2009), including silent mutations and a PRNP 
variant containing three instead of the usual five octapeptide repeats 
(Goldmann et al., 1998) (Table 2). Various European studies have suggested 
that several polymorphisms can modulate scrapie susceptibility in goats as 
well. The presence of methionine (M) at codon 142 was associated with 
increased incubation periods after experimental challenge of BSE and scrapie 
strains (Goldmann et al., 1996) and in natural scrapie outbreaks (Barillet et al, 
2009; González et al., 2010). A reduced susceptibility to natural scrapie has 
also been reported for goats carrying arginine (R) at codon 143, histidine (H) at 
codon 154 (Vaccari et al., 2006; Billinis et al., 2002) or glutamine (Q) at codon 
211 (Barillet et al., 2009). However, H154 has clearly been suggested to be a 
risk factor for Nor98 goat scrapie (Colussi et al., 2008). The most promising 
results have been obtained for codon 146, carrying serine (S) or aspartic acid 
(D), which was linked to high resistance in Cyprus (Papasavva-Stylianou et al., 
2007; 2011), and for codon 222, carrying lysine (K), which in Italy was first 
reported as conferring resistance, being associated only with healthy animals 
(Acutis et al., 2006; Vaccari et al., 2006).  Association of K222 with a 
protective effect was afterwards found also in France and Greece (Barillet et 
al., 2009; Bouzalas et al., 2010). All these results are encouraging to consider 
supporting breeding programs for resistance in goats against classical scrapie 
in all EU Member States, as stated by the EFSA Panel on Biological Hazards 
in the “Opinion on genetic TSE resistance in goats in all EU Member States” 
(2009). Accordingly, the European Commission recently approved the 
Regulation (EC) 189/2011, amending the Regulation (EC) 999/2001, that 
foresees the possibility of delaying the killing and complete destruction of 
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dairy goats in scrapie outbreaks for a maximum period of 18 months or until 
the 31 December 2012 if the index case has been confirmed before 1 July 
2011. In the preliminary remarks is explicitly stated that genetic resistance to 
scrapie in goats could exist and that possibly in 2013 exemption from the 
killing of animals that may be considered resistant in the near future may be 
appropriate. 
 
 
Fig. 2. Physical maps of the ovine PRNP coding sequence and 
polymorphisms 
Features include: thick shaded arrow, coding sequence; black arrow, 3' 
untranslated region of exon 3; hatched arrows, ovine repetitive elements; white 
numbered vertical rectangles, octapeptide repeats; vertical lines, positions of 
SNPs; green single headed arrows, PCR amplification and/or sequencing 
primers (GenBank AY326330). SNP position numbers are distance to the first 
base of the PRNP start codon. Letters below SNPs are IUB ambiguity codes (R 
= a/g, Y = c/t, M = a/c, K = g/t, S = c/g, W = a/t, B = c/g/t, H = a/c/t, D = 
a/g/t). Red numbers and letters indicate sites affected by nonsynonymous 
substitutions at codons 112, 136, 154, 171, and 237. PRNP octapeptide repeats 
at positions 160 to 285 have either five or six repeats (5rep or 6rep). MAF 
histograms correspond to genotypes from approximately 950 sheep available at 
http://cgemm.louisville.edu/USDA/index.html website. 
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Table 2.  Known caprine PRNP gene polymorphisms
a
. 
 
a
Coding polymorphisms in regular print, silent mutations in italics. 
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1.3.2 Role of the PRNP regulatory regions 
In addition to associations between non-synonymous PRNP polymorphisms 
and scrapie occurrence, an inverse relationship between TSE incubation period 
and the level of host PRNP gene expression has also been established in mice 
and cattle (Vilotte et al. 2001; Safar et al. 2005; Sander et al. 2005; Scott et al. 
2005). Two SNPs within the human PRNP gene promoter are considered a risk 
factor associated with spontaneous Creutzfeldt-Jacob disease (CJD) 
(McCormack et al. 2002). In sheep, a significant imbalance in the incidence of 
one SNP (5354-C/A) within the promoter region was found in the closed NPU 
(IAH Edinburgh) Cheviot flock (Hunter et al. 1996; O‟Neill et al., 2005); the 
variant carrying adenine created consensus sequences for STAT transcription 
factor. Electrophoretic mobility shift assays (EMSA) using ovine or murine 
cells and tissues demonstrated differential binding of transcription factors to 
polymorphic variants of the ovine PRNP promoter, suggesting that the prion 
protein expression pattern and the distribution of TSE infectivity may be 
associated with PRNP promoter genotype (Burgess et al. 2009). Studies of the 
regulatory regions of bovine PRNP gene have revealed 46 polymorphisms 
within a 5.4 kb fragment ranging from promoter I to exon II, based on the 
analysis of about 70 animals (Sander et al. 2004). A 23 bp and a 12 bp 
insertion-deletion (indel) polymorphisms within the bovine PRNP promoter 
and intron 1 have been associated with BSE incidence in several domestic 
cattle populations (Sander et al. 2004, 2005; Juling et al., 2006). Both 
sequences contain transcription factor binding motifs, and a functional 
promoter analysis of the different bovine PRNP promoter alleles by reporter 
gene assays demonstrated that bovine PRNP expression in vitro is modulated 
by genetic variation within these regulatory regions (Sander et al., 2005). 
Although the complete goat PRNP gene was recently sequenced (Van Poucke 
et al., 2009) no basic information currently exists regarding the regulation of 
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PRNP transcription and frequency of genetic polymorphism within the 
putative regulatory regions of the goat PRNP gene. 
 
Fig. 3. Schematic overview of the goat PRNP gene organization. 
The thick black line in the middle represents the goat PRNP sequence with 
gray boxes as putative exons, CDS as coding sequence, arrows as repeat 
sequences, „A‟ as putative polyadenylation signal, and black vertical lines as 
mutations found by goat PRNP database sequence comparison. The upper 
window represents the putative promoter sequence with conserved motives and 
putative transcription factor binding sites. The lower window represents all 
known missense (white lines) and silent (black lines) mutations in the CDS. 
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1.4 The Shadow of the Prion Protein gene (SPRN) 
It is clear that PRNP is the major genetic determinant of prion disease 
incubation time; however, it is also apparent that other genes also make a 
significant contribution to the natural variation observed between different 
mouse lines. The greatest amount of incubation time data exists for wild type 
mice (Carlson et al., 1986; Westaway et al., 1987; Lloyd & Collinge, 2005; 
Carlson et al., 1988; Race et al., 1990). Within this group, where the PRNP 
coding sequence is identical, the shortest incubation time described for 
intracerebral inoculation of Chandler/RML prions is 105 ± 4 in SJL/J mice and 
the longest is 221 ± 5 in PWK/Pas mice. This suggests that the combined 
effect of other genes can extend the incubation time by over 100 days, 
effectively doubling the incubation time. Similarly, not all sheep with the same 
PRNP genotype are equally susceptible or develop pathology in the same way 
(Goldmann, 2008) suggesting the involvement of other host genes, amongst 
which the prion family proteins are primary candidates. Beside PRNP, the 
mammalian prion protein gene family currently contains other two known 
genes: PRND (encoding doppel protein, Dpl) and SPRN (encoding shadoo 
protein, Sho) (Premzl et al., 2003; 2004; Premzl & Gamulin, 2007; Watts & 
Westaway, 2007). PrP and Sho are highly expressed in the neurons of the 
central nervous system (Hu et al., 2007; Watts et al., 2007), whereas Dpl 
appears to be specific for the reproductive system (Genoud et al., 2003). The 
more recently discovered Sho protein bears similarity to two features within 
PrP: the hydrophobic domain and a series of tandem repeats with positively 
charged residues. Both of these regions in PrP
C
 are considered to be 
unstructured, or at least less structured than the carboxy-terminal domain (Fig. 
4). Interest in Sho was catalyzed by the observation that it is expressed 
predominantly in the CNS and is perpetuated by a number of PrP-like 
properties (Table 3), beyond mere sequence homology, and by an intriguing 
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downregulation phenomenon in prion infected cells. Dpl, discovered several 
years earlier, bears a resemblance to the carboxyl-terminal globular domain of 
PrP
C
. Dpl is expressed in the male reproductive tract and investigations into its 
biology have centred not only upon reproduction (predictably) but also on the 
unexpected neurotoxic effects of ectopic Dpl expression in the CNS. 
 
 
 
Fig. 4. Domain structure of the PrP protein family. 
Sho, PrP, Dpl, and internally deleted forms of PrP, noted here, generically, as 
DPrP are shown. The proteins are organized around natively unstructured and 
a-helical structured domains. The exact boundaries between the domains are 
approximate. The central hydrophobic tract is indicated by blue diagonal 
shading. For the Sho protein the blue shaded rectangles indicate degenerate 
arginine-glycine-glycine (RGG) repeats. The orange shaded rectangle 
encompasses a different type of arginine-rich tract of the general form 
RVRVRPAPR. White boxes in PrP and Dpl indicate an N-terminal tract of 
charged residues. The diagonally shaded box with black stripes indicates a 
second type of charged patch. CHO indicates N-linked carbohydrates. 
Disulfide linkages are shown by black lines. Alpha helices are shown as 
crimson boxes (aA, aB, and aC) while narrower boxes denote b-strands. GPI 
denotes the glycosylphosphatidyl inositol anchor. 
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Table 3. Properties of PrP, Sho, and Dpl. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
21 
Recently, Watts et al. (2007) hypothesized how the SPRN gene and Sho 
protein may be involved in prion disease, proposing that Sho and PrP bind to 
the same cellular receptor in their neuroprotective role and that perturbation of 
Sho expression during prion disease enhances neuronal death (Fig. 5). 
 
Fig. 5. Molecular model of interaction as hypothesized by Charles 
Weissmann (2001). 
 
 
Association of SPRN with human prion diseases has been demonstrated by 
Beck et al. (2008) who found that a frameshift mutation in SPRN, resulting in 
reduced expression of Sho, is associated with vCJD and that another coding 
mutation (T7M) may be a risk factor for sporadic CJD. A close correlation 
between PRNP and SPRN expression in sheep brain tissue has been suggested 
by Lampo et al. (2009) and Gossner et al. (2009). These findings have 
emphasized the need to understand the genetics of both genes. In sheep, the 
PrP-homologous hydrophobic region of Sho is polymorphic (Fig. 6) and an 
indel polymorphism detected in this region, resulting in the insertion/deletion 
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of two alanine residues, has been associated with susceptibility to classical 
scrapie (Lampo et al., 2010).  
Mouse Sho is post-translationally processed from an ORF of 147 codons, it 
appears in cells as a 18 kDa GPI-anchored membrane protein with one N-
linked carbohydrate (Watts et al., 2007). Lampo et al. (2007) published an 
ovine SPRN ORF encoding a protein of similar overall structure to mouse Sho. 
The most homologous region to PrP is the 20 aa hydrophobic sequence 
AAAGAAAGAAAGAAAGLAAG in sheep Sho protein. In PrP, a 16 aa 
hydrophobic sequence VAGAAAAGAVVGGLGG (sheep codons 115–130) is 
the most conserved part of the protein. Variants of this sequence are very rare, 
only 11 are known in almost 400 PrP variants from over 130 species. There are 
no insertions/deletions in this hydrophobic PrP sequence. It has been suggested 
that the hydrophobic core of PrP is the binding site for other proteins, such as 
stress-inducible protein 1 (STI1) (Zanata et al., 2002), that it modulates the 
formation of transmembrane PrP isoforms (Hegde et al., 1998) and that it is 
important for basolateral sorting of PrP in a cell (Uelhoff et al., 2005). 
Furthermore, the AGAAAAGA palindrome may play a part in the disease-
specific PrP
Sc–PrPC interaction (Norstrom & Mastrianni, 2005): peptides 
containing this sequence are neurotoxic (Forloni et al., 1993) and 
amyloidogenic (Gasset et al., 1992), and the variant AGAAVAGA is linked to 
Gerstmann–Sträussler–Scheinker syndrome, a genetic form of human prion 
disease (Mallucci et al., 1999). The homology in this region between PrP and 
Sho implies that there is similar cellular sorting and ligands and that they use 
similar mechanisms to promote their neuroprotective properties (Chiarini et al., 
2002; Watts et al., 2007). Given the overall degree of conservation of the Sho 
hydrophobic domain it is therefore of considerable interest that deletion and 
insertion variants have been found in this region, in both sheep and bovine 
species and, more rarely, in humans (Daude et al., 2009; Stewart et al., 2009) 
(Fig. 6). These genetic variations may arise because mammalian coding 
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sequences for the Sho hydrophobic domain are arranged as tandem repeats, a 
situation slightly different from the PrP hydrophobic domain, which is 
palindromic. 
 
 
 
 
Fig. 6. Tandem repeats and the structure of the Sho protein. 
(a) Domain structure of the Sho protein. Blue shaded rectangles indicate 
degenerate arginine-glycine-glycine (RGG) repeats with tandem head-to-tail 
organization indicated by gray arrows. An orange shaded rectangle 
encompasses a different type of arginine-rich tract of the general form 
RVRVRPAPR. A central hydrophobic tract is indicated by diagonal shading 
and is itself made up of tandem repeats composed of four amino acids (blue 
arrows). (b) Expanded view and sequence alignment of the hydrophobic tract 
from different species to demonstrate tandem repeat organization. (c) 
Insertion/deletion (indel) allelic variants of the hydrophobic tract seen in 
sheep. Similar, albeit rare, indel variants are also described in humans (not 
shown). 
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Regarding SPRN in goats data are still limited and, at the time of writing, there 
is only one paper in literature by Stewart et al. who sequenced caprine SPRN 
from 135 goats of different breeds and origins. Caprine Sho is 3 aa longer than 
ovine Sho due to an insertion of Leu-Arg-Pro at the very end of the ORF (Fig. 
7). The four identified DNA polymorphisms 144G→A, 177G→C, 300C→T 
and 433C→A (numbered relative to the ORF) were all silent mutations, no 
amino acid changes were detected. The same Authors did not detect amino 
acid polymorphisms in samples from wapiti; domestic cattle and deer samples 
were also very stable, with three allelic variants amongst them. The same 
applies to laboratory mouse strains which, according to the analysis of the 
strains used for scrapie experiments, all express the same Sho. 
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Fig. 7. Alignment of Sho amino 
acid sequences. 
Dots, Identical amino acids; 
dashes, amino acid deletions; 
grey shading, amino acid 
polymorphisms in sheep. 
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1.5 Bioinformatics tools 
Bioinformatics is a relatively recent science and can be defined as the 
application of computer science and information technology to the field of 
biology and medicine. Several bioinformatic tools are currently available for 
the researcher and many of them are freely available on the web. Aim of this 
section of the thesis is to provide an overview of the bioinformatic software 
that has been used to analyse the sequence data generated from the 
experiments. 
 
1.5.1 CpGProD 
CpGProD is a program dedicated to the prediction of promoters associated 
with CpG islands (CGIs) in mammalian genomic sequences. CpGProD is 
available either via a web server (http://pbil.univ-
lyon1.fr/software/cpgprod_query.html), useful for a small dataset, or as a 
standalone application for a larger dataset. The entry sequence (or file) must be 
submitted in FASTA format. In vertebrate genomes, the CpG dinucleotides are 
present at about 25% of their expected frequency. This deficiency is due to the 
methylation of cytosine at CpG dinucleotides and the very high mutation rate 
of the methylated cytosines.  
CGIs are stretches of DNA escaping methylation and exhibiting a high G+C 
content and CpG frequency relative to the bulk DNA. The CGIs are several 
hundreds base to several kilobase long and are dispersed throughout the 
genome. 50%-60% of the human genes exhibit a CGI over their Transcription 
Start Site (TSS) but all the CGIs are not associated with a TSS. 
Some studies (Ioshikhes and Zhang, 2000; Ponger et al., 2001) have shown 
that the CGIs located over the TSS (start CGIs) are characterized by a 
particular structure compared to other CGIs (no-start CGIs): the start CGIs are 
longer and display a greater CpGo/e ratio and G+C level than no-start CGIs. 
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CpGProD computes a score corresponding to the probability to be over the 
TSS (start-p value) from the length, the G+C content and the CpGo/e ratio of 
each CGI. 
Moreover, two compositional biases between the plus and the minus strand of 
the start CGIs were observed in the start CGIs (Ponger, unpublished data). The 
CGIs located over the plus strand exhibit an excess of T compared to A and an 
excess of G compared to C. On the contrary, the CGIs located over the minus 
strand exhibit a depletion of T compared to A and a depletion of G compared 
to C. These biases are estimated by using two parameters, the AT-skew and the 
GC-skew. CpGProD calculates these parameters to predict the strand of each 
potential promoter and the probability to be over this strand.  
 
1.5.2 TFSEARCH 
The TFSEARCH program was written by Yutaka Akiyama (Kyoto University, 
currently at RWCP) in 1995. The TFSEARCH 
(http://www.cbrc.jp/research/db/TFSEARCH.html) searches highly correlated 
sequence fragments against TFMATRIX transcription factor binding site 
profile database in the TRANSFAC databases developed at GBF-
Braunschweig, Germany. TRANSFAC contains data on transcription factors, 
their experimentelly-proven binding sites, and regulated genes. Its broad 
compilation of binding sites allows the derivation of positional weight matrices 
(Fig. 8). Search results are summarized in a tabular form and presented directly 
on the client's web browser. 
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Fig. 8. Examples of positional weight matrices as used by TFSEARCH. 
 
 
 
 
 
1.5.3 PHASE 
The program PHASE (http://stephenslab.uchicago.edu/software.html) 
implements a Bayesian statistical method for reconstructing haplotypes from 
population genotype data. The software can deal with SNP, microsatellite, and 
other multi-allelic loci (eg tri-allelic SNPs, and HLA alleles), in any 
combination, and missing data are allowed. The current version (v2.1) 
implements extensions to the original method that was described in Stephens et 
al. (2001). Experiments with the software on both real and simulated data 
indicate that PHASE can provide an improvement over other existing methods 
for reconstructing haplotypes - for example, in simulation experiments in 
Stephens et al. (2001) the mean error rate using PHASE was about half that 
obtained by the EM algorithm. PHASE algorithm starts by dividing the data 
into segments of consecutive loci. It then computes a list of plausible 
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haplotypes within each segment, and then iteratively combines segments to 
obtain a list of plausible haplotypes, and a best guess for each pair of 
haplotypes, across the whole region. Moreover, PHASE can perform a 
permutation test for significant differences in haplotype frequencies in case 
and control groups. More precisely, PHASE tests the null hypothesis that the 
case and control haplotypes are a random sample from a single set of 
haplotype frequencies, versus the alternative that cases are more similar to 
other cases than to controls. 
 
 
1.5.4 PATROCLES 
Patrocles (www.patrocles.org) is a database of polymorphic miRNA-target 
interactions. Patrocles compiles SNPs in the 3′UTR of human and mouse genes 
that either create or destroy miRNA target sites. miRNA target sites are 
defined as octamer motifs that are expected to show perfect Watson-Crick 
complementarity with the 5′ end of mature miRNAs. The web server provides 
a tool (Patrocles finder) that allows the user to determine whether his favorite 
mutation/polymorphism may perturb miRNA-mediated gene regulation of 
custom target sequences. Specifically, Patrocles finder allows convenient 
examination of the miRNA target site content of a sequence of interest and 
examination of the effect of genetic variants in that sequence on target-site 
content. Patrocles finder analyzes both isolated sequences as well as 
alignments of orthologous sequences in FASTA format. When selecting the 
latter option, Patrocles finder provides direct information about the 
conservation or not of the identified miRNA target sites. 
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Aim of the thesis 
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The research project that I presented at the beginning of my doctorate was 
planned to focus on the study of genetic factors involved in TSE 
resistance/susceptibility in goats. In 2008, when the doctoral course started, 
knowledge on the role of PRNP genetics in goats was preliminary, especially if 
compared with data available for sheep. In the meantime, some studies on goat 
PRNP genetics were published, all looking at the PrP coding sequence. Results 
from these studies clearly indicated the existence of polymorphisms in the 
PRNP open reading frame conferring resistance or, at least, lower 
susceptibility to TSEs in goats. However, the situation in goats seems to be 
different from sheep. Actually, the polymorphisms at codons 136, 154 and 171 
of the ovine PRNP gene are generally diffused in the sheep population and this 
allowed the implementation by the European Union of breeding programmes 
towards scrapie resistance in each Member State according to regulation (EC) 
999/2001. Currently, in goats, the allele carrying lysine (K) at the PrP codon 
222 is the best candidate polymorphism proposed to enhance resistance to 
scrapie and proved to have a protective role both by case-control studies and, 
very recently, by experimental inoculation. Nevertheless, the frequency of the 
K222 mutation is very low or even absent  in a number of goat breeds limiting 
so far the feasibility of a genetic approach for controlling scrapie also in this 
species. Therefore, the knowledge of other genetic factors involved in the 
modulation of the response to the scrapie agent in goats could represent an 
effective control tool as they could be employed in association with the genetic 
selection based on PRNP genetics. For instance, in breeds where the frequency 
of the desired PRNP polymorphisms is very low or null, the existence of other 
genetic targets could allow to initiate disease control and, at the same time, to 
increase/introduce 222K carriers balancing selection towards scrapie resistance 
and preservation of genetic diversity. 
On these basis, the main aim of my research project was to look for TSE 
genetic factors outside the goat PRNP open reading frame by the molecular 
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characterization of the PRNP gene regulatory regions and the assessment of 
the role of the Shadow of the Prion Protein gene (SPRN), a recently discovered 
member of the prion family. In the first part of the research project, the first 
detailed polymorphism study and corresponding haplotype analysis was 
performed to characterize the goat PRNP regulatory regions within 3 kb of the 
transcription start site. A bioinformatic analysis has been applied to the 
primary sequence data generated to identify putative transcription motifs and 
the impact of polymorphisms possibly involving putative transcription motifs 
has been evaluated. Finally, a comparative analysis with respect to other 
mammalian species has been performed. In the second part of the study, the 
analysis of the SPRN genes of goats from several scrapie outbreaks was carried 
out in order to detect polymorphisms and to look for association between 
SPRN alleles and the occurrence of scrapie by a case-control study approach. 
The SPRN gene is a third discovered member of the prion protein gene family 
along with PRNP and PRND (encoding  Doppel protein, Dpl). SPRN encodes 
Shadoo protein (Sho) which shares several structural and biochemical features 
with PrP. As an association of SPRN with human prion diseases has been 
already demonstrated, this gene represent a promising candidate to play a role 
in prion diseases also in other species. However, at the time of writing, data on 
SPRN variability in goats are still very limited and the existence of a potential 
link between SPRN mutations and scrapie completely unknown. 
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Materials and Methods 
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3.1 Animals and DNA isolation 
To characterize the goat PRNP promoter a DNA panel consisting of n = 32 
goats belonging to the following European breeds: Camosciata, Garganica, 
Maltese, Siriana, Ionica, Moncaina, Pirenaica, Retinta and the Hellenic breed 
(Capra prisca) was used (Table 4). Information regarding the PRNP open 
reading frame (ORF) genotypes for all goats were available. Animals included 
in the study were unrelated. Genomic DNA was isolated from whole blood 
using the GenElute Mammalian Genomic DNA kit (Sigma-Aldrich) according 
to the manufacturer‟s protocol. None of the goats utilized in this study had any 
known history or clinical symptoms of TSE. 
To study the relationship between the SPRN gene and scrapie, a panel of 424 
goats was enrolled in the study, including 21 scrapie-positive cases (age range, 
3-10 years) and a control group represented by 403 scrapie negative goats 
taken from ten herds (animals per herd range, 3-103) that had scrapie 
outbreaks between 2002 and 2010. For scrapie diagnosis, the obex region was 
examined by histopathology, immunohistochemistry and/or Western blotting. 
The animals were primarily of the Maltese, Red Mediterranean, Capra dei 
Nebrodi and crossed breeds. Their age ranged from 1 to 9 years. Routine rapid 
tests were performed on the obex region of control animals. Table 5 
summarizes the geographic distribution of the herds and goat breeds. 
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Table 4. Animals used for the study of the PRNP regulatory regions. 
 
 
 
 
Table 5. Herds enrolled in the SPRN case-control study. 
 
Herd Region Breed 
1 Sicilia Capra dei Nebrodi 
2 Basilicata Incrocio 
3 Sicilia Capra dei Nebrodi 
4 Marche Incrocio 
5 Lazio - 
6 Lombardia Saanen 
7 Sicilia Incrocio 
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3.2 Goat PRNP and SPRN PCR amplification 
The regulatory regions of the PRNP gene were analysed by generation of two 
overlapping amplicons covering 2 kb upstream and 1 kb downstream of the 
gene transcription start site (Fig. 9). This 3 kb gene sequence included exon I 
and the putative PRNP promoter. Oligonucleotide primers were obtained from 
Invitrogen (Carlsbad, USA) and the first pair [1F (+) 5‟-
GAGAAGTGGCAATGTAGCTTCC-3‟; 1R (-) 5‟- 
GGGGGTTTAAAGGACTACGTG-3‟] was designed starting from a multiple 
alignment of ovine and bovine promoter sequences. The second primer pair 
was based on the bovine sequence as previously published [PRNP49443_F (+) 
5‟-AGCCGCAGAGCTGAGAG-3‟; PRNP50640_R (-) 5‟-
ACCCGGCCATGAGATAAG-3‟; Sander et al. 2004]. The two amplified 
fragments align to the target PRNP DNA at corresponding nucleotides 3807-
5747 (1F-1R), 5680-6869 (PRNP49443_F-PRNP50640_R) of the ovine PRNP 
sequence (GenBank acc. no. DQ077504). PCR reactions were carried out 
using GeneAmp 9700 PCR Systems (Applied Biosystems, Foster City, USA) 
with the following conditions: 100 ng of genomic DNA, 50 pmol of each 
primer, 100 μM of dNTPs (Fermentas), 1,5 unit of Taq polymerase 
(HotStarTaq, Qiagen) in a final volume of 50 μl of buffer consisting of Tris·Cl, 
KCl, (NH4)2SO4 additioned of Q-solution (Qiagen) and 1.5 mM MgCl2. 
Thermocycling parameters consisted of an initial denaturation step (95 °C, 15 
min) followed by 40 cycles of denaturation (94 °C, 1 min), annealing (58 °C, 1 
min) and extension (72 °C, 1 min). Additionally, primers p8(+) and p9(-) 
annealing on the PRNP exon 3 were used to amplify the open reading frame 
(ORF) for all studied goats as previously described (Bossers et al., 1996).  
A region of the caprine SPRN gene, including the complete ORF and 
fragments of the 5‟UTR and 3‟UTR (Fig. 10), was amplified by setting up 25 
μl PCR reactions containing: 0,4 mM dNTPs (Fermentas), 10x reaction buffer 
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(Roche), 1,5 mM MgCl2, 5x GC-rich solution (Roche), 2U FastStartTaq DNA 
Polymerase (Roche) and 0,4 μM of each primer SPRN-117d (5'-
TGTGCCTGGGCCCTGA-3') and SPRN+166u (5'- 
CCGGCGGGAGGTGTCACA-3'); 100-200 ng of genomic DNA were used as 
template. The following thermal profile was employed: activation of Taq 
polymerase (95°C, 10 min.), followed firstly by 7 cycles using a touch-down 
protocol (95°C, 1 min. - 68°C, 30 sec. - 72°C for 1 min.), and then by 35 
cycles at 95°C for 1 min., 61°C for 30 sec., 72°C for 1 min., with a final 
extension at 72°C for 10 mins.. 
All goat PRNP and SPRN amplicons were examined by 1.5% agarose gel 
electrophoresis and products with the appropriate length were directly purified 
by the silica column method (NucleoSpin Extract II, Macherey-Nagel) 
according to the manufacturer‟s protocol. 
 
Fig. 9. Organization of the caprine PRNP gene and PCR amplification 
strategy. 
 
 
 
Fig. 10. Organization of the caprine SPRN gene and PCR amplification 
strategy. 
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3.3 Cloning and sequencing of the goat PRNP and SPRN genes 
The goat PRNP and SPRN sequences were determined by direct DNA 
sequencing of the PCR products by Big Dye terminator cycle-sequencing using 
the amplification primer pairs (SPRN) and eight internal sequencing primers 
(PRNP). Sequencing strategy was designed to ensure electropherogram 
overlap (Fig. 11), thereby enabling both correct assemblies and verification of 
observed SNPs. For PRNP sequencing, primers annealing on the first fragment 
were 4219F (+) 5'-AGAATAGGACCAAAGGC-3', 5034F (+) 5'-
CCATCCTTCACATGAGA-3', 4593R (-) 5'-GGCTGTTTTCTATCCAG-3' 
and 5320R (-) 5'-CAAAAATTCTACTACCCTG-3'. Primers annealing on the 
second fragment were PRNP49491_F, PRNP50027_R, PRNP50018_F and 
PRNP50558_R (Sander et al., 2004). 
 
Fig. 11. Sequencing strategy of the caprine PRNP regulatory regions. 
 
 
Cycle-sequencing reactions were prepared in a final volume of 10 μl as 
follows: 150 ng of purified amplicon, 2 μl Big Dye v. 3.1 (Applied 
Biosystems), 1 μl Sequencing Buffer, 3.2 pmol primer. Thermal cycling 
parameters followed those recommended by the manufacturer. Purified goat 
PRNP and SPRN amplicons were directly sequenced using the aforementioned 
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internal primers on an ABI Prism® 3130 Genetic Analyzer (Applied 
Biosystems, Foster City, CA, USA). For PRNP analysis, PCR products from 
selected heterozygous samples were cloned into TOPO TA cloning vector 
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer‟s instructions 
(Fig. 12).  
 
Fig. 12. Map showing the features of TOPO TA vector and the sequence 
surrounding the cloning site. 
 
 
At least 12 recombinant cloned plasmids were analysed by multiple sense 
sequencing adding to the employed sequencing primer panel the oligos 
provided with the kit [M13 forward (+) 5‟-
CGCCAGGGTTTTCCCAGTCACGA-3‟ and M13 reverse (-) 5‟-
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AGCGGATAACAATTTCACACAGGA-3‟] annealing on the vector sequence 
and flanking the insert. 
 
3.4 Sequence analysis 
Goat PRNP and SPRN sequences were analysed using the program Sequencing 
Analysis 5.2 (Applied Biosystems). Electropherograms were evaluated by 
manual inspection and looking at the Sequencing Analysis quality score. 
Uncertain bases and presumed heterozygous nucleotides were flagged 
automatically by the program and subsequently assigned by analysis of 
multiple overlapping sequences. All goat PRNP and SPRN sequences were 
assembled using the program SeqMan II v. 5.03 (DNASTAR inc., Madison, 
USA) in order to obtain a consensus sequence for each sample. All 
heterozygous nucleotides were annotated according to the International Union 
of Pure and Applied Chemistry  (IUPAC) and the final consensus sequences 
were assembled into a single data set. Each variable site was enumerated based 
on the corresponding position in the ovine promoter PRNP and caprine SPRN 
reference sequences (Genbank DQ077504 and EU559165, respectively). 
 
3.5 PRNP haplotype analysis 
A dataset including all the individual goat PRNP genotypes was set up. 
Deviations from Hardy-Weinberg equilibrium (HWE) have been reported to 
increase the error rate associated with haplotype inference algorithms (Niu et 
al., 2002; Stephens and Donnelly, 2003). In order to minimize the error rate 
HWE was assessed for each polymorphism by the chi-square test 
(http://www.genes.org.uk/software/hardy-weinberg.shtml). Estimates for the 
goat PRNP haplotype frequencies and the most likely haplotypes were 
reconstructed using a Bayesan statistical method implemented within the 
software package PHASE 2.1 (Stephens et al., 2001; Stephens and Donnelly, 
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2003). Only goat polymorphisms with genotype distributions similar to HWE 
expectations and minor allele frequencies greater than 0.10 were included in 
the haplotype reconstruction analyses.  
 
3.6 PRNP promoter prediction and comparative analysis 
A final PRNP consensus sequence, representative of the goat panel analysed in 
this study, was obtained by the multiple alignment of the consensi derived 
from each sample using BIOEDIT 7.0.5.3 program 
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html). The primary sequence data 
generated were screened against a library of repetitive elements using Repeat 
Masker web-based computer service (http://www.repeatmasker.org/cgi-
bin/WEBRepeatMasker) and submitted to the mammalian-specific program 
CpGProD (Ponger and Mouchiroud 2002; http://pbil.univ-
lyon1.fr/software/cpgprod_query.html) to perform promoter prediction 
analysis. CpGProD has been previously reported to give accurate results based 
on the homology of PRNP regulatory regions predicted for elk and mule deer 
with sequence regions known to possess promoter activity in both cow and 
sheep (Seabury et al., 2007). Additional bioinformatic analyses were 
performed using TFSEARCH 
(http://www.cbrc.jp/research/db/TFSEARCH.html) to study the promoter and 
look for possible transcriptional regulatory elements. The goat PRNP 
consensus sequence was edited manually using EditSeq 5.03 (DNASTAR inc., 
Madison, USA) in order to insert singularly each polymorphic variant before 
submission to TFSEARCH analysis. This approach was aimed to look at the 
influence of the different variants on the creation/deletion of potential 
transcription factor binding motifs. Goat PRNP sequences were also evaluated 
for the presence of four conserved motifs previously identified within the 
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PRNP promoter sequences for human, Syrian golden hamster, sheep, mouse, 
rat, and cow (Westaway et al. 1994; Saeki et al. 1996; Inoue et al. 1997). 
 
 
3.7 Electrophoretic mobility shift assays (EMSA) 
The EMSA technique is based on the observation that protein:DNA complexes 
migrate more slowly than free linear DNA fragments when subjected to non-
denaturing polyacrylamide or agarose gel electrophoresis (Fig. 13) . Because 
the rate of DNA migration is shifted or retarded when bound to protein, the 
assay is also referred to as a gel shift or gel retardation assay. The ability to 
resolve protein:DNA complexes depends largely upon the stability of the 
complex during each step of the procedure. During electrophoresis, the 
protein:DNA complexes are quickly resolved from free DNA, providing a 
"snapshot" of the equilibrium between bound and free DNA in the original 
sample. The gel matrix provides a "caging" effect that helps to stabilize the 
interaction complexes: even if the components of the interaction complex 
dissociate, their localized concentrations remain high, promoting prompt 
reassociation. Additionally the relatively low ionic strength of the 
electrophoresis buffer helps to stabilized transient interactions, permitting even 
labile complexes to be resolved and analyzed by this method. 
The gel shift assay consists of three key steps: (1) binding reactions, (2) 
electrophoresis, (3) probe detection. The order of component-addition for the 
binding reaction is often critical. Completed binding reactions are best 
electrophoresed immediately to preserve potentially labile complexes for 
detection. This idealized example shows complete elimination of the 
protein:probe complex with addition of specific competitor or protein specific 
antibody. However, only a reduction in intensity is observed rather than the 
complete elimination of bands (Fig. 13). 
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Fig. 13. Overview of the Gel Shift Assay Method.  
 
 
 
Typically, linear DNA fragments containing the binding sequence(s) of interest 
are used in EMSAs. If the target DNA is short (20-50 bp) and well defined, 
complementary oligonucleotides bearing the specific sequence can be 
economically synthesized and annealed to form a duplex. For most 
applications and sequences, standard desalting of the oligonucleotides yields 
sufficient purity for use in EMSA. However, for sequences that form strong 
secondary structure or have long repeats, gel- or HPLC-purification may be 
required to ensure that the majority of the product is of the correct length and 
sequence for the experiment. 
In our experiments, complimentary pairs of oligonucleotides (Eurofins MWG, 
Germany) biotinylated at the 3‟ end  and containing the conserved motif 
sequences were annealed forming short double-stranded DNA fragments 
(probes). The following probes (only top strand sequence given) were used: 
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Goat1, 5′-CTCCACCCAGCCCAAGACT-Bio-3′; Goat2, 5′-
CTCCACCCAGCTCAAGACT-Bio-3′; Goat1FL, 5′-
GGACTGCGGGCTTCCGGCGGGCGCGGGGAACGT-Bio-3′.  
DNA probes with known binding sites were used as positive controls. 
Transcription factors were contained in commercially available nuclear 
extracts generated from fibroblast cell line 3T3, from macrophage cell line 
RAW and from total mouse brain (all Active Motif, LaHulpe, Belgium). 
EMSAs were performed using the gel shift assay kit (Thermo Scientific). 
Reactions consisted of 2 μl of 5× binding buffer (250 mm NaCl, 50 mm Tris-
HCl, pH 7.5, 2.5 mm EDTA, 2.5 mm dithiothreitol, 5 mm MgCl
2
, 20% 
glycerol, 0.5 μg poly(dI·dC)·poly(dI·dC)), 1–2 μl (10–20 μg) NE, and dH2O to 
a total volume of 20 μl incubated at 25 °C for 10 min. To the reaction mixture 
1 μl of biotnylated double-stranded DNA probe (0.035 pmol, ~10,000–50,000 
cpm/10–100 fmol) was added and further incubated at 25 °C for 20 min. For 
competition experiments a 200-fold molar excess of unlabeled competitor 
and/or non-competitor (NC-1) double-stranded DNA probes were added. The 
reactions were electrophoresed in a 6% non-denaturing polyacrylamide gel in 
0.5× Tris-buffered EDTA at 100 mA at room temperature for 1 h. DNA was 
then blotted onto nylon membrane for 40 min at 380mA. After UV cross-
linking, biotin/strepavidine interaction was monitored by chemiluminescence 
detected by exposure to x-ray film. 
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3.8 Statistical analysis (SPRN case-control study) 
To assess the role of SPRN polymorphisms in the susceptibility of goats to 
scrapie a case-control study was carried out. The “case” was considered as an 
animal diagnosed definitively scrapie positive after the compulsory 
confirmatory diagnostic tests. The “control” was an animal coming from the 
same herds as the cases and therefore exposed to the scrapie agent, but resulted 
negative for scrapie by routine rapid testing. To estimate the relationship 
between the polymorphisms in the host SPRN gene and the occurrence of 
scrapie we carried out a preliminary univariate analysis computing Pearson χ2 
test and then a logistic regression model was fitted including the variables 
resulted positively associated with the outcome (i.e. the scrapie status). We 
considered information about SPRN gene polymorphisms, goat breed, herd and 
age. In the regression model the number of the positive cases was included as 
dependent variable to estimate the role of the polymorphisms in the host SPRN 
gene. The animal breed was included into the model as covariate in order to 
assess its potential effect. After analysing the distribution of the cases and the 
controls for the different breeds, we aggregated all the pure breeds in an unique 
category and we compared its effect with the cross-bred animals. To avoid 
biased results due to the prevailing effect of PRNP polymorphisms in the 
control group, 49 controls that resulted to be carriers of the protective 222K 
allele were excluded from the analysis. Finally, 375 animals were entered in 
the model. As the PRNP genotyping was available only for codon 222 in the 
control animals, we took into account the possible occurrence of histidine (H) 
at codon 154 (another protective allele in goats) by a simulation model 
considering the frequencies of the 154H allele reported for different Italian 
breeds (Acutis et al., 2008). Specifically, we considered 154H allele 
frequencies of 11.3% for the Camosciata delle Alpi, 0% for the Saanen, 11.2% 
for the Garganica, 6% for the Maltese, 7.4% for the Ionica, 5.3% for the 
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Siriana, 8% for the Capra dei Nebrodi and 5% for the cross-bred. For other 
goat breeds we set 154H frequencies equal to 50%. A Monte Carlo simulation 
was performed to simulate the occurrence of the 154H allele in the control 
group executing 5000 replications and a logistic regression for each 
simulation. In the regression model the number of the positive cases was 
included as dependent variable while the animal breed (all pure breeds vs 
cross-bred) and the simulated 154H allele frequencies were included as 
covariates. The mean of the estimated odds ratios and their significance for the 
included variables was analysed for the total simulations. All descriptive 
statistics and data manipulation were performed using Stata Statistical 
Software (StataCorp LP). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
47 
 
 
 
 
 
Results and Discussion 
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4.1 Molecular characterization of the putative regulatory regions 
of the prion protein gene (PRNP) in goats 
 
PCR products of the expected molecular  size (approximately 1940 bp and 
1190 bp, respectively) were obtained using primers and optimized protocols 
described in the Methods section (Fig. 14). 
 
Fig. 14. PCR products corresponding to the putative goat PRNP 
regulatory regions. 
 
 
1940 bp 
1190 bp 
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Sequence analysis of 3 kb PRNP non coding region of goats from different 
European breeds resulted in the identification of 26 previously unreported 
diallelic SNPs (Fig. 14 and Fig. 15).  
 
Fig. 14. Graphical representation of the polymorphisms identified in the 
goat PRNP promoter (numbering referred to ovine ref. seq. DQ077504). 
 
 
 
Only one SNP was detected within the predicted exon 1 of a goat belonging to 
Ionica breed. Moreover, analysis of electropherograms and sequence 
alignments yielded evidence of three novel indels among the studied samples 
(Fig. 18). Indel polymorphisms were not found in homozygosis in the analysed 
animals therefore they were firstly observed as frame shifts in the sequence 
electropherograms (Fig. 15) and then confirmed by cloning of heterozygous 
samples (Fig. 16) and alignment of single chromosomal sequences (Fig. 17). 
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Fig. 15. Electropherogram presenting a frame shift (arrow) due to an 
indel polymorphism in heterozygosis. 
 
 
 
Fig. 16. PCR performed on recombinant E.coli colonies for PRNP indel 
characterization. 
 
1.9 kb 
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Fig. 17. Alignment of sequences derived from recombinant E coli clones. 
Each panel (A, B, C) corresponds to an indel polymorphism identified in the 
goat PRNP intron I. Numbering is referred to ovine ref. seq. DQ077504. 
 
A. 
 
 
B. 
 
 
C. 
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Fig. 18. Graphical representation of the polymorphisms identified in the 
goat PRNP exon 1 and Intron I (numbering referred to ovine ref. seq. 
DQ077504). 
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A list of the identified polymorphisms with the indication of their position in 
the goat PRNP and relative allele frequencies is shown in Table 6.  
 
Table 6. 
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No genetic variation was observed within the four conserved PRNP promoter 
motifs previously described for mouse, sheep, human, Syrian golden hamster, 
rat, and cow (Westaway et al., 1994; Saeki et al.1996; Baybutt and Manson 
1997; Inoue et al. 1997) (Fig. 19). 
 
Fig. 19. Alignment of four promoter motifs conserved across mammalian 
PRNP sequences. 
 
 
 
PRNP promoter prediction analyses for cow (AJ298878), sheep (DQ077504), 
and goat are depicted in Table 7. CpGProD software predicted a single plus-
strand goat PRNP promoter with a predicted probability to be located over this 
strand corresponding of 0.8857 (strand-p). The putative regulatory region was 
identified by the software between nucleotides 1405 and 3005 of the query 
(3005 nt masked consensus sequence submitted) corresponding to bases 5265-
6859 and 49028(3743)-50630(5361) of the homologous sheep and cattle PRNP 
sequences, respectively.  
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Table 7. PRNP promoter prediction and comparative analyses. 
 
 
 
Nucleotide sequence alignment of the predicted goat PRNP promoter 
(CpGProD) with the PRNP region of known promoter activity in sheep 
(O‟Neill et al., 2003) revealed the presence of one SNP in the homologous 
region of goat (5677-G/A, Table 6). In such region SNPs 5354-C/A and 5622-
C/G are linked to transcription factor binding motif profile in sheep. Variants 
5454-A and 5622-G create additional STAT and Sp1 transcription factor 
binding sites (O‟Neill et al., 2003). All analysed caprine sequences carry 5354-
A and 5622-G. Likewise human and cattle also goats do not seem to be 
polymorphic at these sites based on our results. Similarly, comparative 
alignments made between the PRNP regions of known promoter activity in 
cow (Inoue et al., 1997) and the predicted goat PRNP promoter revealed nine 
SNPs and one indel (5808-T/G, 5844-G/A, 5869-G/T, 5911-C/T, 6171-G/C, 
  
56 
6206-G/C, 6352-C/G, 6431-T/C, 6460-G/T, 6466 C-del) in the homologous 
caprine sequence. No PRNP SNPs were in common among sheep, cow and 
goat. However, looking at the complete alignment assembly it appears that 
sheep and goat share a polymorphic site flanking the 3‟ end of the region 
known to have promoter activity in sheep (5808-C/G in sheep, 5808-T/G in 
goat). 
Ten out of the 29 observed polymorphisms displayed a minor allele frequency 
less than 0.10 (Table 6) and were therefore excluded from haplotype analysis. 
The remaining polymorphisms were tested for genotype distribution similar to 
HWE and nine resulted to deviate from HWE expectations. Based on 10 
polymorphic sites (9 SNPs and one indel), thirteen goat PRNP haplotypes were 
predicted using PHASE 2.1 best reconstruction and best pairs analysis. Figure 
20 shows the predicted haplotypes (n = 13) and estimates of the sample 
haplotype frequencies. PHASE 2.1 analysis retrieved also the most likely 
haplotype pair for each goat included in the study (data not shown).  
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Fig. 20. PHASE haplotype reconstruction and frequencies. 
  
Analysis performed using TFSEARCH aimed to evaluate the presence of 
transcription factor binding sites within the region of interest. In the present 
study sequencing of the goat PRNP gene was extended 2 kb upstream and 1 kb 
downstream the transcription start site. This allowed us to perform in silico 
identification of putative transcription binding sites outside the core promoter 
region. TFSEARCH analysis was done through two approaches as described 
below. 
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4.1.1 Alignment of the goat PRNP sequence with the ovine homologous 
sequence and evaluation of the presence of goat additional or defective 
transcription factor binding sites based on basic nucleotide differences among 
the considered consensus sequences. 
 
Alignment of ovine and goat homologous sequences showed several 
mismatches and some of them potentially differentiate the binding site profile 
of the two species (Fig. 21). At position 4068 (numbering according to ovine 
DQ077504) the ovine sequence carries a T, responsible for potential Ikaros 
(Ik-2, Ik-3) binding sites on minus strand, while the caprine sequence carries a 
C, creating a consensus motif for AP-1 binding site lying on the same strand. 
The presence of adenine at position 4484 of the goat sequence (4484-C in 
sheep) generate a putative binding site for the cardiac transcription factor Nkx-
2.5 (Evans, 1999). The consensus sequences Nkx-2.5 in the upstream promoter 
region might also be relevant for the regulation of cell-specific promoter 
activity since PrP
C
 mRNA and protein are also expressed in the heart (Manson 
et al, 1992; Bendheim et al., 1992). At position 4568 the sheep reference 
sequence carries a T, while the obtained goat consensus carries a A. This 
change leads to the loss of a potential E4BP4 binding site in goat (Fig. 21, ▬). 
E4BP4 protein was recently recognized as transcription factor binding to 
conserved motif 2 by electrophoretic mobility shift assays. Functional 
promoter analysis of four different promoter variants revealed that motif 2 
(E4BP4) was linked to a slight enhancing activity (Burgess et al., 2009). 
Conversely, the insertion of a T at position 4730 of the goat sequence enhance 
the binding site profile in this species creating consensus motifs for Oct-1 (plus 
strand) (Fig. 21, ▬) and TATA (minus strand) transcription factors. Oct-1 is a 
ubiquitous transcription factor but also controls tissue-specific genes including 
several in brain or lymphatic cells (reviewed by Sytina and Pankratova, 2003). 
Another caprine potential Oct-1 binding site is given by the combination of 
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nucleotide changes at positions 4906 and 4917 (thymines in sheep are replaced 
by cytosines at both positions in goat). Interestingly, the lack of the G at 
position 5494 in the goat sequence (A substitution) affects the consensus 
sequence for a putative Sp1 binding site (Fig. 21, ▬). Even though this Sp1 
motif is not located so close to the transcription start site, it could compensate 
the minor number of Sp1 binding factors present in the core promoter of sheep 
PRNP with respect to other related ruminant species. In fact, the only Sp1 site 
proximal to the sheep PRNP exon 1 start site is subjected to a change (5622-C) 
that creates an AP2 consensus sequence (Dynan et al., 1986). In contrast to the 
sheep PRNP sequence, three Sp1 sites have been identified in the homologous 
region of the bovine and caprine PRNP sequences (Inoue et al., 1996; Van 
Poucke et al., 2009). A potential Lyf-1 motif on the minus strand of sheep 
PRNP exon 1 is abolished in goat by CG change at position 5708. The same 
happens for the c-Rel binding site in Intron I of sheep which is affected by 
GC change at position 5841 of goat PRNP (Fig. 21, ▬). C-Rel has been 
characterized as a potential candidate transcription factor in the PRNP 
promoter of human neuronal cells (Funke-Kaiser et al., 2001). NF-κB/Rel 
proteins might be relevant during amyloid-related neurodegenerative processes 
(Grilli and Memo, 1999). Position 6051 seems to be important in the PRNP 
transcription binding site profile because the presence of guanine in goat 
(replacing cytosine at the homologous sheep position) potentially creates three 
overlapping binding sites in this species: GATA-1, GATA-2 and p300. 
Transcription factors of the GATA family have been implicated in 
hematopoiesis and cardiac development (Charron and Nemer, 1999) but are 
also expressed in embryonic and adult central nervous system (Pandolfi et al., 
1995; Nardelli et al., 1998). Homozygous knock-out mice lacking GATA-2 
exhibit, for example, neurogenesis defects in the hindbrain (Nardelli et al., 
1998). p300 is a transcriptional coactivator that interact with a large number of 
transcription factors and regulate transcription through multiple mechanisms. 
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Conditional transgenic mice expressing an inhibitory truncated form of p300 
have impaired long-term recognition memory and contextual fear memory 
(Oliveira et al., 2007). At positions 6404 and 6409 two close nucleotide 
mismatches have the effect of deleting a putative MZF-1 binding site in goat. 
MZF-1 regulates cellular proliferation, but it is also a negative regulator of 
expression of the mouse extracellular superoxide dismutase (EC-SOD or 
SOD3) (Zelko and Folz, 2003). At position 6486 the goat consensus sequence 
lacks a potential CP2 binding site (cytosine with guanine substitution). CP2 is 
a ubiquitously expressed transcription factor present in regulatory regions of 
multiple erythroid genes. In these regions, the CP2 binding site is usually 
adjacent to a site for the erythroid factor GATA-1. Interestingly, the sheep 
PRNP binding motif profile displays the same organization with a GATA-1 
motif flanking the predicted CP2 binding site. The disruption of a potential 
interaction between these two binding factors in goat could have a significance 
considering that PrP
C
 is expressed on hematopoietic cells, including erythroid 
precursors and that the expression of the erythroid differentiation-related factor 
(EDRF) is reduced in lymphatic tissues of rodents and cattle as well as in 
whole blood of sheep that suffer from TSEs (Miele et al., 2001; Brown et al., 
2007).  
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Fig. 21. Alignment of sheep and goat PRNP regions under study. 
 
*Squares indicate putative TF binding sites created by sequence differences. 
References in the text to each site are pointed out by coloured bars (▬). 
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A nine base pair TGCTCCGGA insertion starting from position 6525 is 
present in all the analysed goat and creates the consensus sequence for a 
potential Elk-1 binding site (Fig. 21, ▬). Elk-1 is an ETS-like gene that codes 
for a DNA binding protein that is involved in transcriptional activation, 
proliferation and differentiation. Elk-1 is an activator of Mitogen-Activated 
Protein (MAP) kinases and induces apoptosis (Rao et al., 1989; Hipskind et al., 
1991; Rao and Reddy, 1994; Shao et al., 1998). At position 6834 the goat 
sequence shows a TC substitution with respect to sheep. This change turns 
out in the loss of a potential Interferon-Stimulated Response Element (ISRE) 
in goat. Regulatory regions of interferon-inducible genes often contain ISRE 
which is predominantly stimulated by type 1 interferons. Microglial 
transcriptional changes are detectable beginning at 30 days after innoculation 
in CJD brain. In particular, 10 interferon-sensitive genes were upregulated at 
very early stages of infection (Baker et al., 2004). In mouse models, one 
mechanism has been suggested by which increased interferon responsive gene 
expression may enhance disease progression (Stobart et al., 2007). 
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4.1.2 Submission to TFSEARCH of the identified variants of the goat PRNP 
gene to evaluate the possible effect of polymorphisms on the transcription 
binding site profile.  
A putative AML-1A binding site (minus strand) was identified by TFSEARCH 
linked to the 4054-C variant. The AML1 gene encodes several transcription 
factors, including AML1A, which bind to DNA via a TGT/cGGT consensus 
sequence that is found in several promoters (Meyers et al., 1993). 
Polymorphism at position 4463 gives rise to an additional Sp1 transcription 
factor binding site when the variant carrying cytosine is present, adding a 
fourth enhancer motif to the three Sp1 binding sites present immediately 
upstream exon 1 in goat (Van Poucke et al., 2009). The Sp1 transcription 
factor has been shown experimentally to play a role in transcriptional 
regulation of PRNP (Saeki et al., 1996; Baybutt & Manson 1997; Inoue et al., 
1997; Mahal et al., 2001). 
Variant 5183-G leads to a putative CdxA transcription factor binding site on 
the plus strand and two additional CdxA motifs on the minus strand. Another 
CdxA motif is created by 6756-T variant in Intron I (minus strand). 
Interestingly, the SNP at position 5808 (5808-T) and the two single nucleotide 
indel polymorphisms (6466-C deletion and 6579-G insertion) identified in 
Intron I, could have a similar influence on the regulation of PRNP expression. 
In fact, they all give origin to putative LyF-1 transcription factor binding sites. 
The transcription factor LyF-1 can be considered a candidate for binding to the 
PRNP promoter region, because the consensus binding site TCAGGGAG is 
identical to the conserved motif 4 (TCAGGGAG) (Lee et al., 1998). At the 
polymorphic position 6206 the presence of glycine creates a putative binding 
motif for Myb transcription factor. The Myb proteins bind to DNA and 
regulate gene expression. These proteins are defined by the Myb domain, a 
sequence of approximately 50 amino acids with a structure similar to the helix-
turn-helix motif of prokaryotic transcriptional repressors and eukaryotic 
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homeodomains (Ganter et al., 1999). Interestingly, the variant carrying 
adenosine at position 6557 affects a myeloid zinc finger-1 (MZF-1) potential 
regulatory element. This motif was one of the seven motifs (among 51 short 
conserved sites) found fully conserved within Intron I of human, mouse, 
bovine, ovine, and tamar wallaby from Premzl et al. (Premzl et al., 2004). 
When SNP at position 6707 and adjacent MNP at position 6708 were 
combined to give a CCC triplet an additional Sp1 binding site was recognized 
by TFSEARCH, lying in Intron I on the minus strand. The occurrence of the 
less frequent variant of polymorphism at position 6795 (6795-A) originates a 
CCAAT/Enhancer-binding Protein (C/EBP) alfa binding site on the minus 
strand. C/EBPs comprise a family of transcription factors that are critical for 
normal cellular differentiation and function in a variety of tissues (Lekstrom-
Himes and Xanthopoulos, 1998). Results of the TFSEARCH analyses and 
identified putative transcription factors with the frequency of the binding and 
non-binding alleles are summarized in Table 8.  A graphical representation is 
also shown in Fig. 22. The putative Sp1 binding site created by the C/T 
polymorphism and located in the promoter region at 1203 bp from the 
transcription start site (highlighted in Table 8) was selected for the subsequent 
EMSA experiments. 
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Table 8. Polymorphisms within the goat PRNP regulatory regions that 
affect transcription factor-binding sites. 
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Fig. 22. Graphical representation of transcription factor-binding sites 
affected by polymorphisms within the goat PRNP regulatory regions. 
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4.2 EMSA analysis of putative TF binding motifs in the PRNP 
promoter and Intron I sequence 
 
As described above sequence analysis of the non coding regions of the caprine 
Prnp gene and interspecies comparison of this gene region allowed the 
identification of putative TF binding motifs. Some of these putative motifs 
were polymorphic in the caprine gene and others are species specific when 
compared with other ruminants. A molecular understanding of the PRNP gene 
regulation would benefit the evaluation of polymorphisms and the potential 
relevance for disease phenotypes. It was decided to perform “electrophoretic 
mobility shift assays (EMSA)” to establish molecular interaction of TFs with 
PRNP promoter and intron 1 regions based on the caprine gene sequence. 
Two putative motifs were selected: 
1) A Sp1 putative binding site identified in the goat promoter (-1203 from 
the transcription start site, Table 6) and linked to the C allele of the 
4463T/C polymorphism (Table 8, Fig. 22). The haplotype frequency for 
this polymorphism has 44% C to 56% T. We decided to include this site 
for EMSA experiments as it appeared to be highly variable in the studied 
goats and it is known that Sp1 is a common regulator protein, which has 
been indicated in cattle to be associated with different PRNP expression 
and possibly BSE susceptibility. 
2) A region of Intron I close to exon 1 showing conservation by 
comparative alignment of ruminant species (Fig. 23) and a striking 
overlap of not less than four putative TF binding sites, including c-Rel, 
ELK1, Sp1 and MZF1. This region also contains a polymorphisms 
decribed previously by us  for the caprine gene and a species specific 
difference between goats and sheep on the one side and cattle on the 
other. 
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Fig. 23. Alignment of intron 1 from PRNP gene sequences from 
different ruminant species. 
 
The EMSA targeting the -1203 Sp1 binding site demonstrated that, under 
standard conditions, no shift was observable using 3T3 cell line extract for 
both alleles. As control the biotinylated probe carrying the Sp1 consensus 
motif showed a characteristic band shifted to the top of the blot (gel)  (Fig. 24). 
This control shift was also confirmed as Sp1-related by comparison with 
previous EMSA data. We conclude that neither of the caprine PRNP 
haplotypes in this position is able to bind Sp1 with significant efficiency and 
therefore Sp1 is not likely to control PRNP gene expression through the -1203 
position. 
Fig. 24. Gel shift assay targeting the putative -1203 Sp1 binding site. 
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Even though this experiment seem to exclude binding of the predicted Sp1 
factor at this site, it must be taken into account that EMSA is very sensible to 
experimental conditions and adjustments to the protocol could be introduced to 
assess whether this is the real result or binding can occur under optimized 
conditions. 
In contrast to the above EMSA result, when using the intron 1 ELK1 
containing sequence we were able to demonstrate the formation of a complex 
with the two celll line extracts (RAW & 3T3). This complex was competed by 
the ELK1 unlabeled probe (Fig. 25). However, it is also likely that other TFs 
bind to this position as predicted from the alignment. RAW cell extracts 
showed also additional smaller complexes with Goat1FL probe which were 
similar to Sp1 complexes in size but might not consist of Sp1. Subsequently, 
the Goat1FL probe and biotinylated Sp1c control were also loaded with 
recombinant Sp1 TF showing that Goat1FL does not bind Sp1. In conclusion, 
the analysed conserved sequence from the PRNP promoter represented by the 
Goat1FL oligo binds ELK1 TF and probably two other factors, probably cREL 
and MZF, which need to be tested in future experiments. 
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Fig. 25. Gel shift assay targeting the Intron I sequence. 
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4.3 Role  of the SPRN gene in goat susceptibility/resistance to 
classical scrapie 
 
4.3.1 Genetic variability of the caprine SPRN gene 
A total of 11 mutations were found in the caprine SPRN gene; ten were SNPs 
and one was an indel polymorphism (Table 9). A polymorphism was 
considered as such when it was found in three or more animals.  
 
Table 9. 
 
 
 
Five synonymous SNPs in the SPRN ORF (codon (c.) 48G>A, c.59G>C, 
c.61G>C, c.100T>C, c.145C>A) and four polymorphisms in the 3‟UTR 
(positions 573G>A, 602_606insCTCCC, 624G>T, 645G>T) had been reported 
previously (Stewart et al. 2009), while two novel non-synonymous mutations 
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were identified. They were located in the ORF and were detected at very low 
incidence: at codon 142, a CGG→TGG substitution caused an amino acid 
change of Arg to Trp, and at codon 145, an AGG→TGG substitution led to the 
amino acid change Arg to Trp (Fig. 26). No change was found in the 
hydrophobic alanine region of the gene. 
 
Fig. 26. Electropherograms showing two novel coding mutations detected 
in the caprine SPRN ORF. 
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4.3.2 SPRN case-control study 
Table 10 shows the cases and the controls breeds and their proportion (data 
were not available for 12 animals). The cross-bred animals represented 27.4% 
of the studied sample. 
 
 
 Table 10. Case and control breeds and their proportion. 
 
Breed 
Cases 
(%) 
Controls 
(%) 
Total (%) 
Alpina 0 (0) 16 (4.0) 16 (3.8) 
Bionda 
Adamello 
0 (0) 1 (0.30) 1 (0.24) 
Camosciata 1 (4.8) 48 (11.9) 49 (11.6) 
Capra dei 
Nebrodi 
1 (4.8) 95 (23.6) 96 (22.6) 
Frisa 0 (0) 6 (1.5) 6 (1.4) 
Garganica 1 (4.8) 0 (0) 1 (0.24) 
Maltese 1 (4.8) 79 (19.6) 80 (18.9) 
Saanen 0 (0) 24 (6.0) 24 (5.7) 
Siriana 0 (0) 23 (5.7) 23 (5.4) 
Cross-bred 16 (76.2) 100 (24.8) 116 (27.4) 
Missing 1 (4.8) 11 (2.8) 12 (2.8) 
Total 21 (100) 403 (100) 424 (100) 
 
 
The results of the bivariate analysis are shown in the Table 11. In the 3‟UTR, a 
polymorphism causing the insertion of five nucleotides (602_606insCTCCC) 
was found to be associated with susceptibility to scrapie in goats (p = 0.028). 
The genotype SPRN and the breed showed a significant association with the 
disease. 
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Table 11. Distribution of considered factors among cases and controls. 
 
 
 
Category Cases (%) Controls (%) P-value (*) 
Genotype  
SPRN 
   0.028 
 1. No mutation 11 (52.4) 299 (74.2)  
 2. Mutation 10 (47.6) 104 (25.8)  
Genotype  
PRNP 
   0.089 
 1. No mutation 0 (0) 49 (12.2)  
 2. Mutation 21 (100) 354 (87.8)  
Breed    0.00 
 1. Pure breeds 4 (20) 292 (74.5)  
 2. Cross-breed 16 (80) 100 (25.5)  
(*) Pearson χ2 
 
Table 12 shows the results of the logistic regression model. Even including the 
breed as covariate, the polymorphisms in the host SPRN gene resulted 
associated with the disease.  
 
Table 12. Results of the logistic regression model analysis.  
 
Covariate Category OR 95% CI 
Genotype  SPRN 1. No mutation Referent  
 2. Mutation 2.5 1.03-6.11 
Breed  1. Pure breeds Referent  
 2.  Cross-breed 12.1 3.88-37.59 
OR=odds ratios, CI: confidence interval. Pseudo R2: 0.18; LR χ2,  
p-value: 0.00 
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In the Table 13 a descriptive analysis of the results of the models, including the 
Monte Carlo simulation (5000 replications) of occurrence of histidine at codon 
154 of the PRNP gene, is presented. In 96% of the models the polymorphisms 
in the host SPRN gene was still associated with the disease while the presence 
of the 154H allele was unlikely to affect SPRN association with scrapie.   
 
Table 13. 
Variable 
Mean of the  
estimated 
OR 
Min. 
observed 
Max 
observed 
Significant OR / 
total estimated 
OR 
*100 
Genotype  SPRN 
(mutation vs. no 
mutation) 
 
2.9 
 
2.0 
 
3.6 
 
96% 
Breed 
(cross-breed vs. 
pure breed) 
 
12.7 
 
10.0 
 
49.9 
 
100% 
154H allele 
(presence vs. 
absence) 
0.84 0.03 3.5 6.7% 
OR=odds ratios 
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4.3.3 microRNA target prediction 
In silico analysis for microRNA targets using the program PATROCLES 
(http://www.patrocles.org) predicted multiple putative binding sites for miR-
149* in this specific region of the SPRN gene (Fig. 27). The allele carrying the 
602_606CTCCC insertion created an additional target site for miR-149*, a 
recently identified cognate miRNA of miR-149 (Lin et al., 2010). 
 
Fig. 27. Graphical representation of prediction analysis of microRNA 
target sites in the SPRN 3’UTR. 
 
MicroRNAs (miRNAs) are ~22 nt noncoding RNAs that negatively regulate 
target gene expression and play important roles in multiple biological and 
metabolic processes of eukaryotic organisms and in disease (e.g. cancer). Most 
miRNA genes are first transcribed into long transcripts of primary miRNAs 
(pri-miRNAs) by RNA polymerase II. The pri-miRNAs are then processed by 
Drosha to generate the ~80 nt precursor miRNAs (pre-miRNAs) with the stem-
loop structure. After being exported from nucleus into cytoplasm, premiRNAs 
are further processed by Dicer to produce the mature miRNAs. Sometimes, 
there are two mature miRNAs originated from the opposite arms of the same 
pre-miRNA, which may be differentially expressed. In that case, the mature 
sequence of the predominant product is assigned as the specific „„miRNA‟‟ 
and the minor product as „„miRNA*‟‟ (Fig. 28). So far, the mutual relationship 
and interactions of miRNA and its cognate miRNA* have not been elucidated 
yet. 
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Fig. 28. Human precursor miR-149 stem-loop is processed into two miRNAs, 
miR-149 and miR-149* (adapted from the miRBase; 
http://microrna.sanger.ac.uk/sequences/index.shtml). 
 
 
To our knowledge information on the physiological tissue expression profile of 
miR-149* are currently not available, however, looking at the expression 
profile of the predominant miR-149, as reported by the microRNA.org 
database (www.microrna.org) it can be noticed that, among normal tissues, it is 
highly expressed in nervous tissues (Fig. 29). Even though this finding is 
obviously far to be a proof of an analogous expression profile for miR-149*, it 
is intriguing when associated to the observation that the expression of miR-
149* has been demonstrated to inhibit the growth of a neuroblastoma cell line, 
Be2C cells and HeLa cells by inducing apoptosis (Lin et al., 2010). 
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Fig. 29. miR-149 expression levels at various tissues. 
 
 
 
 
Moreover, a comparison of the surrounding region of the 3‟UTR revealed large 
insertions / deletions between species and also as polymorphism in caprine 
SPRN (Fig. 30). Caprine SPRN has a deletion of 33 bp compared to all other 
sequences whereas a 21 bp insertion characterized the cervine SPRN 3‟UTR.  
Within the approximately 120 bp 3‟UTR which was sequenced here we found 
a (T/G)CCC motif repeated between nine and eleven times depending on 
species and allele. The sequence GCCCTCCTCCC is highly conserved in 
these ruminants whereas further downstream the number of direct repeats of 
Frontal cortex 
Midbrain 
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this motif vary between four and six between species or in the case of  the 
caprine 3‟UTR between two alleles. These motifs are conserved in human 
SPRN, but not in mouse SPRN (not shown). It remains to be tested whether 
they have a role in post-transcriptional or translational modulation of gene 
expression.  
 
Fig. 30. Variation in the 3’ UTR of the SPRN gene across ruminants. 
                          
 TAGGCTGGGCCCGGCGCGTCTGAGCCAGAGCCGCCCCCAGCCTGTGCCCTCCTCCCAGGCCTCGC--------      sheep        
                                     TAGGCCTGTGCCCTCCTCCCAGGCCTCGC--------      goat 
 TAGGCTGGGTCGGGCGCATCCGGGCCAGAGCCGCCCCCAGCCTGTGCCCTCCTCCCAGGCCTCAC--------      oryx 
 TAGGCTGGGCCGGGCGCATCCGGGCCAGAGCCGCCCCCAGCCTGTGCCCTCCTCCCAGGCCTCAC--------      gems  
 TAGGCTGGGCCGGGCGCATCAGGGCCAGAGCCGCCCCCAGCCTGTGCCCTCCTCCCAGGCCCCGC--------      cattle  
 TAGGCTGGGCTGGGCGCGTCCTGGCAAGAGCCGCCCCCAGCCTGTGCCCTCCTCCCAGGCCCCAT--------      lechwe 
 TAGGCTGCGCCGGGCACACCAGGGCCAGAGCCGCCCCCAGCCTGTGCACTCCTCCCAGGCCCCGC--------      kudu   
 TAGGCTGGGCCGGGCACACCAGGGCCAGAGCCGCCCCCAGCCTGTGCCCTCCTCCCAGGCCCCGC--------      nyala  
 TAGGCTGGGCTGGGCGCTTCCGG-CCAGAGCTGCCCCCAGCCTGTGCCCTCCTCCCAGGCCCCGCAGCCACCT      deer 
 TAGGCTGGGCCGGGCGCATCAGGGCCAGAGCCGCCCCCAGCCTGTGCCCTCCTCCCAGGCCCCGC              yak 
 
 ------------AGCCCCGA-TCGCCC-TCCCCTCCCCTCCCCTCCCC-----ACAGCCAGGAGCCTAGAACAACG   sheep 
 ------------AGCCCCGA-TCGCCC-TCCCCTCCCCTCCCTTCCCCTCCCCGCAGCCAGGAGCCTAGAGCAACG   goat 
 ------------AGCCCTGA-TCGCCCCTCCCCGCCCCTCCCC----------ACAGCCAGGAGCCTGGAGCAACG   oryx 
 ------------AGCCCTGA-TCGCCCCTCCCCGCCCCTCCCC----------ACAGCCAGGAGCCTGGAGCAACG   gems 
 ------------GGCCCCGA-TCGCCCCTCCCCTCCCCTGCCC----------ACAGCCAGGAGCCTAGAGCAGTG   cattle 
 ------------GGCCCCGA-TCGCCCCTCCCCTCCCCTGCCC----------ACAGCCAGGA                lechwe  
 ------------GGCCC-GATT-GCCCCTCCCCTCCCCTGCCC----------ACAGCCACGGGCCTAGAGCAGCG   kudu 
 ------------GGCCC-GACT-GCCCCGCCCCTCCCCTCCCCTGCCC-----ACAGCCACGGGCCTAGAGCAGTG   nyala 
 TAGAGGCTACCCAGCCCTGA-TCGCCCCTTCCCTCCCCTGCCC----------ACAGCCAGGAGCCTAGA         deer 
 ------------GGCCCCGA-TCGCCCCTCCCCTCCCCTGCCC----------ACAGCCAGGAGCCTAGAGCAGTG          
                      |--1--||-2-||-3-||-4-||-5-||-6-| 
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Conclusions 
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The results of this study provide further insight in the field of goat TSE 
genetics as it represents the first polymorphism analysis of the goat PRNP 
putative regulatory regions and the first association study investigating the role 
of the goat SPRN gene in scrapie occurrence.  
Twenty-nine novel polymorphisms were identified within a 3 Kb region 
encompassing the PRNP transcription start site in goats belonging to nine goat 
breeds coming from Italy, Greece and Spain. None of the identified changes 
were identical to bovine and ovine variants demonstrated to be involved in 
gene expression. The goat PRNP promoter prediction, generated using the 
program CpGProD online, was homologous to the regions of known promoter 
activity of both cattle and sheep. This result was not unexpected given that 
BLAST analysis yielded that the analysed goat PRNP region has the best 
nucleotide homology with sheep and cow (max identity of 96% and 92%, 
respectively). Haplotype analysis, performed on the study goats using 
bioinformatics, predicted 13 haplotypes based on ten polymorphic sites. The 
estimated haplotype frequencies indicate that three major haplotypes 
(numbered 3, 4 and 8 in Fig. 20) represent over 65% of the genetic variability 
in the study goats. Most of the polymorphisms with an influence on the 
presence/absence of transcription factor binding sites were found in Intron 1. 
Only three identified SNPs are located upstream the transcription start site 
(4054-C, 4463-C, 5183-G) and they are all outside of the core promoter region 
and of the predicted CpGProD promoter. However, the finding of control 
elements inside Intron 1 is not unusual. Many genes have conserved regulatory 
regions located within the intron sequences, which may contribute to the 
control of gene expression. Control elements are preferentially found located 
in the 5‟ introns with less control elements found in the introns located further 
downstream. The enhancer effects of these control regions are so essential that 
some genes will not be expressed in their absence. In addition, these control 
elements may be involved in the tissue specific expression of the gene product. 
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Actually, our preliminary functional studies have also demonstrated that a 
conserved region in the PRNP intron I is able to bind different TFs, among 
which the binding of ELK1 has been assessed by EMSA experiments. 
Therefore it appears that ELK1 could be a regulator of PRNP transcription, 
which has been previously suggested based on cell experiments. Moreover, 
bioinformatics analysis identified ten polymorphisms that could have an effect 
on regulation of PRNP expression level in goats. They could be selected as 
primary targets to be investigated in functional assays as well as in case-
control studies.  
In the course of the research project, novel data about the genetic variability of 
the caprine SPRN gene have also been generated showing that, similarly to 
cattle, the Shadoo protein appears to be highly stable in goats. Conservation of 
the Shadoo protein in goats could be regarded as unexpected if one consider 
the parallelism proposed by other Authors (Daude et al., 2009) between 
genetic variability of PRNP and SPRN genes. This was based on the 
observation that low degrees of nucleotide diversity were found in human and 
mouse SPRN and PRNP genes, while a number of coding alterations occur 
both in PRNP and SPRN in sheep. Therefore a common selection pressure 
acting on these two genes of the prion family was hypothesized. On these 
basis, as the caprine PRNP gene carries many missense polymorphisms, a 
similar scenario might be expected for the SPRN gene; nevertheless, the lack 
of coding polymorphisms in the studied goat sample, indicate that, al least in 
Italy, this seems not to be the case. The most remarkable finding from the 
SPRN study is the identification of an indel polymorphism in the 3‟UTR 
(602_606insCTCCC ) associated with the susceptibility to classical scrapie in 
goats from Italian outbreaks. This indel occurs in a region of the SPRN 3‟UTR 
highly conserved in ruminants and characterized by repetitive motifs. 
Bioinformatics analyses suggest the hypothesis that the detected polymorphism 
may contribute to modulation of susceptibility to the disease via gene 
  
83 
expression regulation by a miRNA-mediated post-transcriptional mechanism. 
Even though TSE association studies are notoriously difficult and require 
confirmation by experimental exposure to different TSE strains of animal 
carrying the alleles of interest, the identification of a genetic target outside the 
PRNP gene could improve future genetics-based scrapie control approaches 
(e.g., by helping to overcome limitations due to the low frequency of the 
desired PRNP polymorphisms in some goat breeds). However, further studies 
are needed to assess whether genetic differences in the 3‟UTR of the SPRN 
gene could modulate other aspects of disease such as pathology or subclinical 
infection.  
In conclusion, the results presented in this Doctoral thesis provide novel 
knowledge on genetic factors outside the PRNP open reading frame 
investigating their influence in the modulation of scrapie susceptibility in 
goats. These data could provide a significant contribution to the control of 
classical scrapie in goats as well as further research opportunities on other 
aspects related to the function and pathogenicity of the prion protein.   
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